Splice modification to restore functional dystrophin synthesis in Duchenne muscular dystrophy.

Overview of attention for article published in Current Pharmaceutical Design, January 2010

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

patent: 14 patents

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 14 patents that reference this research output.

OPA1 antisense oligomers for treatment of conditions and diseases

Grant US-12753408-B2

United States of America

06 Oct 2026

Antisense oligomers for treatment of conditions and diseases

Grant US-12577561-B2

United States of America

17 Mar 2026

OPA1 antisense oligomers for treatment of conditions and diseases

Grant US-12338437-B2

United States of America

24 Jun 2025

Methods and compositions for treatment of cholesteryl ester storage disease

Grant US-12060558-B2

United States of America

13 Aug 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 10 additional patents.